Award
National Cancer Institute 1OT2CA278700-01
NextGen - CRI
Recipient
CHILDREN'S RESEARCH INSTITUTE, WASHINGTON, DC, UNITED STATES
Award Amount
$871,168.00
Ceiling
$871,168.00
Awarded
June 22, 2022
Identifier
1OT2CA278700-01
The award supports research to develop engineered T-cell therapies for pediatric solid cancers by identifying targets, studying tumor microenvironment, engineering T-cells, and translating findings into clinical studies.
Description
Next Generation T cell therapies for childhood cancers [NexTGen]. This project focuses on developing advanced cellular engineering approaches for pediatric solid tumors, with an emphasis on target discovery, understanding tumor microenvironment, and clinical translation of engineered T-cell therapies.